194 related articles for article (PubMed ID: 22424185)
1. Synthesis, characterization, and in vitro studies of bis[1,3-diethyl-4,5-diarylimidazol-2-ylidene]gold(I/III) complexes.
Liu W; Bensdorf K; Proetto M; Hagenbach A; Abram U; Gust R
J Med Chem; 2012 Apr; 55(8):3713-24. PubMed ID: 22424185
[TBL] [Abstract][Full Text] [Related]
2. NHC gold halide complexes derived from 4,5-diarylimidazoles: synthesis, structural analysis, and pharmacological investigations as potential antitumor agents.
Liu W; Bensdorf K; Proetto M; Abram U; Hagenbach A; Gust R
J Med Chem; 2011 Dec; 54(24):8605-15. PubMed ID: 22091836
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological studies of silver N-heterocyclic carbene complexes derived from 4,5-diarylimidazole.
Liu W; Bensdorf K; Hagenbach A; Abram U; Niu B; Mariappan A; Gust R
Eur J Med Chem; 2011 Dec; 46(12):5927-34. PubMed ID: 22019187
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, antitumor, and antibacterial activity of bis[4,5-diarylimidazol-2-ylidene]methane derivatives.
Liu W; Chen X; Gust R
Arch Pharm (Weinheim); 2012 Jul; 345(7):557-64. PubMed ID: 22467535
[TBL] [Abstract][Full Text] [Related]
5. Gold(I) carbene complexes causing thioredoxin 1 and thioredoxin 2 oxidation as potential anticancer agents.
Schuh E; Pflüger C; Citta A; Folda A; Rigobello MP; Bindoli A; Casini A; Mohr F
J Med Chem; 2012 Jun; 55(11):5518-28. PubMed ID: 22621714
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological activity of ester- and amide-functionalized imidazolium salts and related water-soluble coinage metal N-heterocyclic carbene complexes.
Pellei M; Gandin V; Marinelli M; Marzano C; Yousufuddin M; Dias HV; Santini C
Inorg Chem; 2012 Sep; 51(18):9873-82. PubMed ID: 22946642
[TBL] [Abstract][Full Text] [Related]
7. Gold(I) complexes with thiosemicarbazones: cytotoxicity against human tumor cell lines and inhibition of thioredoxin reductase activity.
Lessa JA; Guerra JC; de Miranda LF; Romeiro CF; Da Silva JG; Mendes IC; Speziali NL; Souza-Fagundes EM; Beraldo H
J Inorg Biochem; 2011 Dec; 105(12):1729-39. PubMed ID: 22005449
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, structural characterisation and anti-proliferative activity of NHC gold amino acid and peptide conjugates.
Lemke J; Pinto A; Niehoff P; Vasylyeva V; Metzler-Nolte N
Dalton Trans; 2009 Sep; (35):7063-70. PubMed ID: 20449149
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and pharmacological evaluation of 1H-imidazoles as ligands for the estrogen receptor and cytotoxic inhibitors of the cyclooxygenase.
Wiglenda T; Ott I; Kircher B; Schumacher P; Schuster D; Langer T; Gust R
J Med Chem; 2005 Oct; 48(20):6516-21. PubMed ID: 16190777
[TBL] [Abstract][Full Text] [Related]
10. Benzimidazol-2-ylidene gold(I) complexes are thioredoxin reductase inhibitors with multiple antitumor properties.
Rubbiani R; Kitanovic I; Alborzinia H; Can S; Kitanovic A; Onambele LA; Stefanopoulou M; Geldmacher Y; Sheldrick WS; Wolber G; Prokop A; Wölfl S; Ott I
J Med Chem; 2010 Dec; 53(24):8608-18. PubMed ID: 21082862
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, characterization, and antitumor activity of unusual pseudo five coordinate gold(III) complexes: distinct cytotoxic mechanism or expensive ligand delivery systems?
Olsen PM; Ruiz C; Lussier D; Le BK; Angel N; Smith M; Hwang CB; Khatib R; Jenkins J; Adams K; Getcher J; Tham F; Chen ZG; Wilson EH; Eichler JF
J Inorg Biochem; 2014 Dec; 141():121-131. PubMed ID: 25243390
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and characterization of azolate gold(I) phosphane complexes as thioredoxin reductase inhibiting antitumor agents.
Galassi R; Burini A; Ricci S; Pellei M; Rigobello MP; Citta A; Dolmella A; Gandin V; Marzano C
Dalton Trans; 2012 May; 41(17):5307-18. PubMed ID: 22391922
[TBL] [Abstract][Full Text] [Related]
13. Anticancer cyclometalated [Au(III)m(C(wedge)N(wedge)C)mL]n+ compounds: Synthesis and cytotoxic properties.
Li CK; Sun RW; Kui SC; Zhu N; Che CM
Chemistry; 2006 Jul; 12(20):5253-66. PubMed ID: 16642532
[TBL] [Abstract][Full Text] [Related]
14. Stable anticancer gold(III)-porphyrin complexes: effects of porphyrin structure.
Sun RW; Li CK; Ma DL; Yan JJ; Lok CN; Leung CH; Zhu N; Che CM
Chemistry; 2010 Mar; 16(10):3097-113. PubMed ID: 20162647
[TBL] [Abstract][Full Text] [Related]
15. Structural and solution chemistry, protein binding and antiproliferative profiles of gold(I)/(III) complexes bearing the saccharinato ligand.
Maiore L; Cinellu MA; Michelucci E; Moneti G; Nobili S; Landini I; Mini E; Guerri A; Gabbiani C; Messori L
J Inorg Biochem; 2011 Mar; 105(3):348-55. PubMed ID: 21421122
[TBL] [Abstract][Full Text] [Related]
16. Gold(I) complexes of water-soluble diphos-type ligands: synthesis, anticancer activity, apoptosis and thioredoxin reductase inhibition.
Wetzel C; Kunz PC; Kassack MU; Hamacher A; Böhler P; Watjen W; Ott I; Rubbiani R; Spingler B
Dalton Trans; 2011 Sep; 40(36):9212-20. PubMed ID: 21826354
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, structure and cytotoxicity studies of four-coordinate bis (cis-bis(diphenylphosphino)ethene) gold(I) complexes, [Au(dppey)(2)]X.
Healy PC; Loughrey BT; Williams ML; Parsons PG
J Inorg Biochem; 2010 Jun; 104(6):625-31. PubMed ID: 20346516
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, characterisation and biological properties of gold(III) compounds with modified bipyridine and bipyridylamine ligands.
Casini A; Diawara MC; Scopelliti R; Zakeeruddin SM; Grätzel M; Dyson PJ
Dalton Trans; 2010 Mar; 39(9):2239-45. PubMed ID: 20162197
[TBL] [Abstract][Full Text] [Related]
19. Luminescent alkynyl-gold(I) coumarin derivatives and their biological activity.
Arcau J; Andermark V; Aguiló E; Gandioso A; Moro A; Cetina M; Lima JC; Rissanen K; Ott I; Rodríguez L
Dalton Trans; 2014 Mar; 43(11):4426-36. PubMed ID: 24302256
[TBL] [Abstract][Full Text] [Related]
20. A gold(I) phosphine complex containing a naphthalimide ligand functions as a TrxR inhibiting antiproliferative agent and angiogenesis inhibitor.
Ott I; Qian X; Xu Y; Vlecken DH; Marques IJ; Kubutat D; Will J; Sheldrick WS; Jesse P; Prokop A; Bagowski CP
J Med Chem; 2009 Feb; 52(3):763-70. PubMed ID: 19123857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
